전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,045 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleXuekui LiuPhase 2

Zimberelimab (Zimberelimab)

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable · Prostatic Neoplasms, Castration-Resistan

#ProstaticNeoplasmsCastration-Res#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 50Status Recruiting
AntibodyLimited DatastaleBiogenPhase 2

90-Y-ibritumomab tiuxetan (90-Y-ibritumomab tiuxetan)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#monoclonal-antibody#Biogen
Trials 49Status Active
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

CD7 CAR T-cells (CD7 CAR T-cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · Crohn Disease

#CrohnDisease#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 49Status Active
ADCLimited DatastaleAstellas Pharma Incvedotin after avelumabPhase 1

Enfortumab (Enfortumab)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#antibody-drug-conjugate#vedotin+2
Trials 49Status Active
AntibodyCurated CorestaleEpizyme, Inc.Phase 3

Mosunetuzumab (Mosunetuzumab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · FRα

#FR#Antibody#Phase3#BioJungboMoa-pick#monoclonal-antibody+4
Trials 49Status Recruiting
AntibodyLimited DatastaleMridula George, MDPhase 2

Retifanlimab (Retifanlimab)

Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Breast Carcinoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#AnatomicStageIVBreastCancerAJCCv+3
Trials 49Status Recruiting
AntibodyLimited DatastaleBristol-Myers SquibbPhase 2

Belatacept (Belatacept)

Highly Sensitized Prospective Kidney Transplant Recipients · Kidney Transplantation

#KidneyTransplantation#Antibody#Phase2#monoclonal-antibody#HighlySensitizedProspectiveKidne+2
Trials 48Status Active
ADCLimited DatastaleADC TherapeuticsPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#antibody-drug-conjugate#DiffuseLargeB-CellLymphoma+2
Trials 48Status Recruiting
AntibodyLimited DatastaleEpizyme, Inc.Phase 2

Tafasitamab (Tafasitamab)

Relapsed Hematologic Malignancy; Refractory Hematologic Malignancy · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#monoclonal-antibody#RelapsedHematologicMalignancy+3
Trials 48Status Discontinued
CGTLimited DatastaleSun Yat-sen UniversityPhase 2

Relmacabtagene Autoleucel (Autoleucel, Autoleucel (Relmacabtagene Autoleucel))

Large B Cell Diffuse Lymphoma; Mantle Cell Lymphoma (MCL) · Large B Cell Diffuse Lymphoma

#LargeBCellDiffuseLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 47Status Recruiting
CGTLimited DatastaleShenzhen Hornetcorn Bio-technol…Phase 1

Autologous NK cell therapy (Autologous NK cell therapy)

NK Cell Mediated Immunity; Endometriosis · NK Cell Mediated Immunity

#NKCellMediatedImmunity#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 47Status Active
AntibodyLimited DatastaleChia Tai Tianqing Pharmaceutica…Phase 2

Penpulimab (Penpulimab)

Advanced Malignant Neoplasm · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedMalignantNeoplasm+2
Trials 47Status Active
CGTLimited DatastalePoseida Therapeutics, Inc.Phase 2

autologous anti-BCMA chimeric antigen receptor T cells (autologous anti-BCMA chimeric antigen receptor T cells)

ITP · BCMA

#BCMA#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 47Status Active
ADCLimited DatastaleAstellasPhase 3

EV/P (enfortumab vedotin and pembrolizumab, enfortumab vedotin and pembrolizumab (EV/P))

Advanced Bladder Cancer · Advanced Bladder Cancer

#AdvancedBladderCancer#ADC#Phase3#antibody-drug-conjugate#ADCsandimmunotherapyhavechangedt+1
Trials 47Status Recruiting
CGTLimited DatastaleVaxcell Bio, Co., Ltd.Phase 1

Autologous Natural Killer Cell Therapy (Autologous Natural Killer Cell Therapy)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 46Status Recruiting
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 3

Autologous cytokine-induced killer cell (Autologous cytokine-induced killer cell)

Small Cell Lung Cancer · Small Cell Lung Cancer

#SmallCellLungCancer#CGT#Phase3#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleFondazione Policlinico Universi…Preclinical

Cell function identification (Cell function identification)

Bronchiolitis Obliterans Syndrome (BOS) · Bronchiolitis Obliterans Syndrome (BOS)

#BronchiolitisObliteransSyndromeB#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 46Status Discontinued
CGTLimited DatastaleCenter for International Blood …Phase 2

Chronic Myeloid Leukemia + NK cell (Chronic Myeloid Leukemia + NK cell)

Chronic Myeloid Leukemia · Chronic Myeloid Leukemia

#ChronicMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 46Status Active
CGTLimited DatastaleGeneplus-Beijing Co. Ltd.Phase 2

DC-CIK (DC-CIK)

Renal Cell Carcinoma · Renal Neoplasma

#RenalNeoplasma#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 46Status Recruiting
AntibodyLimited DatastaleImmunityBio, Inc.Phase 2

NAI (Nogapendekin Alfa-Inbakicept, Nogapendekin Alfa-Inbakicept (NAI))

Acute Respiratory Distress Syndrome; Severe Community-Acquired Pneum · Acute Respiratory Distress Syndrome

#AcuteRespiratoryDistressSyndrome#Antibody#Phase2#monoclonal-antibody#SevereCommunity-AcquiredPneum+2
Trials 46Status Discontinued

12 / 103 pages

← PreviousNext →